Advertisements

Aurobindo Q4 PAT seen up 25.3% YoY to Rs. 648.2 cr: Edelweiss

Aurobindo Q4 PAT seen up 25.3% YoY to Rs. 648.2 cr: Edelweiss.....»»

Category: topSource: moneycontrolApr 16th, 2018

Bombay HC asks Reliance Power, Edelweiss to try resolving share sale issue

Bombay HC asks Reliance Power, Edelweiss to try resolving share sale issue.....»»

Category: topSource: moneycontrolMar 12th, 2019

GMDC jumps 10% after Edelweiss initiates coverage with buy call, sees 22% upside

GMDC jumps 10% after Edelweiss initiates coverage with buy call, sees 22% upside.....»»

Category: topSource: moneycontrolMar 12th, 2019

Investing principles from Warren Buffet, Phil Fisher and Sir John Templeton

Investing principles from Warren Buffet, Phil Fisher and Sir John Templeton.....»»

Category: topSource: moneycontrolFeb 16th, 2019

Investing principles from Warren Buffet, Phil Fisher Sir John Templeton

Investing principles from Warren Buffet, Phil Fisher Sir John Templeton.....»»

Category: topSource: moneycontrolFeb 16th, 2019

OCBC"s Bank of Singapore ties-up with India"s Edelweiss to tap wealth market

OCBC"s Bank of Singapore ties-up with India"s Edelweiss to tap wealth market.....»»

Category: global-financeSource: reutersFeb 14th, 2019

Pledged share sale: Reliance Power drags Edelweiss group to Bombay HC, but gets no relief

Pledged share sale: Reliance Power drags Edelweiss group to Bombay HC, but gets no relief.....»»

Category: topSource: moneycontrolFeb 13th, 2019

Aurobindo completes acquisition of Apotex"s businesses in 5 European countries

Aurobindo completes acquisition of Apotex"s businesses in 5 European countries.....»»

Category: economySource: sifyFeb 11th, 2019

Aurobindo acquires Apotex#39;s ops in 5 European countries

Aurobindo acquires Apotex#39;s ops in 5 European countries.....»»

Category: topSource: moneycontrolFeb 11th, 2019

Analysts remain positive on Aurobindo Pharma, expect stock to return 8-30% after Q3 earnings

Analysts remain positive on Aurobindo Pharma, expect stock to return 8-30% after Q3 earnings.....»»

Category: topSource: moneycontrolFeb 11th, 2019

Illegal action by LT, Edelweiss entities caused fall in mkt capitalisation: Reliance Group

Illegal action by LT, Edelweiss entities caused fall in mkt capitalisation: Reliance Group.....»»

Category: topSource: moneycontrolFeb 8th, 2019

Aurobindo Pharma Q3 FY19 net profit zooms 19.7% to Rs 712.2 crore, beats analysts#39; estimates

Aurobindo Pharma Q3 FY19 net profit zooms 19.7% to Rs 712.2 crore, beats analysts#39; estimates.....»»

Category: topSource: moneycontrolFeb 7th, 2019

Aurobindo Pharma Q3 preview: Here#39;s what brokerages will focus on

Aurobindo Pharma Q3 preview: Here#39;s what brokerages will focus on.....»»

Category: topSource: moneycontrolFeb 6th, 2019

Edelweiss bets on 8 largecap and 6 midcap stocks post Budget 2019

Edelweiss bets on 8 largecap and 6 midcap stocks post Budget 2019.....»»

Category: topSource: moneycontrolFeb 5th, 2019

Aurobindo Pharma, Dr Reddy#39;s Labs, Strides Pharma, Wockhardt to get astrological support: Satish Gupta

Aurobindo Pharma, Dr Reddy#39;s Labs, Strides Pharma, Wockhardt to get astrological support: Satish Gupta.....»»

Category: topSource: moneycontrolJan 29th, 2019

Axis Bank Q3 profit likely to grow sharply, NII growth could be over 10%

Axis Bank Q3 profit likely to grow sharply, NII growth could be over 10%.....»»

Category: topSource: moneycontrolJan 28th, 2019

Edelweiss Fin Q3 net profit down 4% to Rs 226.1 crore; stock falls 5%

Edelweiss Fin Q3 net profit down 4% to Rs 226.1 crore; stock falls 5%.....»»

Category: topSource: moneycontrolJan 24th, 2019

Stocks in the news: RIL, HUL, Lupin, Aurobindo Pharma, Cyient, LT Tech, AU Small Finance

Stocks in the news: RIL, HUL, Lupin, Aurobindo Pharma, Cyient, LT Tech, AU Small Finance.....»»

Category: topSource: moneycontrolJan 17th, 2019

Aurobindo to acquire 7 oncology products from US firm

Aurobindo to acquire 7 oncology products from US firm.....»»

Category: topSource: mydigitalfcJan 17th, 2019

Aurobindo buys 7 oncology injectable drugs in $300 million deal

Aurobindo buys 7 oncology injectable drugs in $300 million deal.....»»

Category: topSource: moneycontrolJan 17th, 2019

Edelweiss#39; alternative investment fund-II raises Rs 9,200 crore

Edelweiss#39; alternative investment fund-II raises Rs 9,200 crore.....»»

Category: topSource: moneycontrolJan 17th, 2019